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Heterotrimeric G protein signaling is important for cell-proliferative
and glucose-sensing signal transduction pathways in the model plant
organism Arabidopsis thaliana. AtRGS1 is a seven-transmembrane,
RGS domain-containing protein that is a putative membrane receptor
for D-glucose. Here we show, by using FRET, that D-glucose alters the
interaction between the AtGPA1 and AtRGS1 in vivo. AtGPA1 is a
unique heterotrimeric G protein  subunit that is constitutively
GTP-bound given its high spontaneous nucleotide exchange coupled
with slow GTP hydrolysis. Analysis of a point mutation in AtRGS1 that
abrogates GTPase-accelerating activity demonstrates that the regu-
lation of AtGPA1 GTP hydrolysis mediates sugar signal transduction
during Arabidopsis development, in contrast to animals where nu-
cleotide exchange is the limiting step in the heterotrimeric G protein
nucleotide cycle.
D-glucose  G protein-coupled receptor  guanine nucleotide cycle 
RGS protein  GTPase-accelerating protein
G protein-coupled receptors (GPCRs), also known as seven-transmembrane domain (7TM) receptors, compose a large
superfamily of cell membrane proteins that convert extracellular
signals from environmental cues to intracellular responses (1–3).
Both genetic and biochemical data firmly support a role for G
proteins in sugar-regulated plant cell proliferation, yet plants
have a limited repertoire of heterotrimeric G protein-signaling
components (4–10). Arabidopsis thaliana has one canonical G
protein  (G) subunit (AtGPA1), one G subunit, and two G
subunits, but, as yet, no bona fide GPCR (although candidate
GPCRs have been proposed) (10, 11). The Arabidopsis regulator
of G protein signaling-1 (AtRGS1) protein contains seven
transmembrane-spanning domains and a C-terminal RGS do-
main (5). Thus, AtRGS1 has the membrane topology and
structural characteristics of a GPCR, and genetic evidence is
consistent with AtRGS1 being a receptor or coreceptor for
D-glucose at the plasma membrane (4, 5). The RGS domain of
AtRGS1 has GTPase-accelerating activity toward AtGPA1 in
vitro and AtRGS1 functions in the AtGPA1-regulated, sugar-
sensing, and cell-proliferation pathways in vivo (4, 5, 12).
Based on these previous findings, it has been proposed that
AtRGS1 could be a guanine-nucleotide exchange factor (GEF)
and/or a GTPase-accelerating protein (GAP) for AtGPA1 (3,
13). A ligand for AtRGS1 that modulates GEF or GAP activity
has not been identified. However, based on the altered sugar
responsiveness of Atrgs1-null mutants, it has been suggested that
D-glucose is a candidate ligand (4–8). Here we examined the
requirement for G protein signaling in the Arabidopsis glucose-
sensing pathway. Conventional GPCRs serve as nucleotide
exchange factors controlling the rate-limiting step in heterotri-
meric G protein cycling: the release of GDP (14). We found that
the Arabidopsis AtRGS1 protein serves as a 7TM GAP, and it is
GTP hydrolysis, not GDP release, by AtGPA1 that is rate-
limiting in Arabidopsis D-glucose signal transduction.
Results and Discussion
Growth arrest during Arabidopsis development can be induced
by high concentrations of D-glucose and quantified by the
fraction of seedlings with green cotyledons (4, 15). At 1%
D-glucose, individuals of all Arabidopsis genotypes that were
tested grew normally (100% green seedlings) (data not shown),
whereas at 6% glucose, approximately half of the individual
wild-type seedlings arrested (Fig. 1A). As expected (4), AtRGS1-
deficient plants were tolerant to 6% D-glucose, whereas
AtGPA1-deficient plants were hypersensitive to glucose-induced
growth arrest (Fig. 1 A). Likewise, Arabidopsis overexpressing
wild-type AtRGS1 were hypersensitive to glucose-induced
growth arrest (Fig. 1 A). Plants lacking both AtGPA1 and
AtRGS1 also were hypersensitive to glucose (Fig. 1 A), pheno-
copying the Atgpa1 mutant phenotype of glucose hypersensitiv-
ity. This finding indicates that AtGPA1 and AtRGS1 work in the
same glucose signal transduction pathway, and that the null
Atgpa1 allele is epistatic to the null Atrgs1 allele in this pathway.
These data suggest that, in the presence of ligand (high concen-
trations of glucose), a signal transduction pathway inhibits plant
growth and development. This pathway is modulated by hetero-
trimeric G protein signal transduction, and AtGPA1-GTP most
likely attenuates an antiproliferative pathway (6). We hypothe-
size that this process is modulated by AtRGS1 acting as a glucose
sensor and regulating the GTPase activity of AtGPA1. There-
fore, based on this hypothesis, glucose should alter the interac-
tion between AtRGS1 and AtGPA1, thereby coupling receptor
activation to the modulation of AtGPA1’s activity on seedling
developmental processes.
To test this prediction in vivo, we performed FRET studies on
plants coexpressing AtGPA1-CFP and AtRGS1-YFP fusion pro-
teins (e.g., Fig. 1 B–G). Within 6 min after the addition of exogenous
D-glucose, FRET increased (Fig. 1G, arrows). The change in FRET
was transient, peaking at 8–10 min and decaying with a half-life of
2 min. Interestingly, FRET signals were exclusively observed on
or around plastids that were in close proximity to the plasma
membrane. The observed FRET was specific to D-glucose because
it was not observed upon the addition of L-glucose (Fig. 1H) or
mannitol [supporting information (SI) Fig. 4]. Thus, both genetic
and imaging data are consistent with the hypothesis that AtRGS1
is a membrane receptor or coreceptor for D-glucose that interacts
with AtGPA1 upon glucose binding. However, the imaging data do
not preclude a mechanism in which indirect modulation of FRET
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may occur by an alternative glucose-sensing pathway. The imaging
data further suggest that downstream signal transduction may be
spatially localized where plastids abut the plasma membrane. This
finding is consistent with evidence showing that the plastid protein
THF1 directly interacts with AtGPA1 at the plastid/plasma mem-
brane interface, and that the thf1-null allele is epistatic to the
Atgpa1-null allele in the sugar-sensing pathway (6).
Based on its chimeric structure (N-terminal 7TM and C-
terminal RGS domains), we previously hypothesized that
AtRGS1 could be a D-glucose-regulated GAP, GEF, or dual
GAP and GEF for AtGPA1 (3). Our present analysis of the
biochemical properties of AtGPA1 is consistent with the former
(glucose-regulated GAP) and suggests that the AtGPA1
GTPase cycle does not require GEF activity. Recombinant
AtGPA1 had a high specific activity, binding [35S]GTPS with a
stoichiometry of 0.91 mol of GTPS/mol of protein. Equilibrium
competition binding assays with a variety of purine and pyrim-
idine nucleotide triphosphates were conducted. Only guanine
nucleotide triphosphates were able to compete with [35S]GTPS
for binding to AtGPA1 (SI Table 1), indicating that AtGPA1 is
selective toward guanine nucleotides and is a bona fide GTP-
binding protein. The observed rate of [35S]GTPS binding to
AtGPA1 was fast (kobs  1.4 min1). However, this value is likely
an underestimate because the first time point shows 75%
binding in this assay format (Fig. 2A). Human GoA had a kobs
value of 0.09 min1 in this GTPS-binding assay (Fig. 2 A),
consistent with it being one of the fastest exchanging mammalian
G subunits described (SI Table 2). To obviate the poor
temporal resolution of the [35S]GTPS-binding assay, we used
fluorescence spectroscopy to quantitate the kinetics of AtGPA1
binding to BODIPYFL-GTPS (Fig. 2B). By using this real-time
assay, the kobs value for GTPS binding by AtGPA1 was 14.4
min1, a value 22-fold faster than the most rapidly exchanging
G subunits previously described (SI Table 2). To verify this
result by using an independent approach, we measured GTPS
binding to AtGPA1 by using intrinsic tryptophan fluorescence,
and comparable kinetic data were obtained (kobs  8.7 min1)
(Fig. 2C). To ensure that the high rate of nucleotide exchange
observed was not the result of nonphysiological Mg2 concen-
trations, we measured GTPS-binding rates at different con-
centrations of free magnesium. The rate of GTPS binding was
independent of [Mg2]free over a wide range (2 M–20 mM) (SI
Fig. 5), indicating that the nucleotide exchange rate observed in
vitro is likely to be similar in vivo. We also directly measured GDP
release by using [-32P]GDP-bound AtGPA1 (Fig. 2D). The rate
of GDP dissociation from AtGPA1 (koff  12.6 min1) was
highly concordant with the measured GTPS-binding rate.
GDP dissociation is the rate-limiting step of the heterotrimeric
G protein cycle as described in animals (14). To understand the
exceptionally rapid nucleotide exchange exhibited by AtGPA1 in
the context of its complete nucleotide cycle, we also measured
the rate of GTP hydrolysis by AtGPA1 by using a single turnover
GTPase assay. The kcat value for AtGPA1 at 20°C was 0.12 min1
(Fig. 2E), making AtGPA1 among the slowest heterotrimeric
GTPases described (SI Table 2). The kcat value of GoA was
determined in parallel (Fig. 2E) and was consistent with pub-
lished values (SI Table 2). This observation demonstrates that
the rate of GTP hydrolysis (kcat) by AtGPA1 is over two orders
of magnitude slower than the rate of nucleotide exchange (koff).
Thus, GTP hydrolysis (rather than GDP release) is the rate-
limiting step in the guanine nucleotide cycle of AtGPA1. Two
predictions follow from these observations: (i) The steady-state
rate of GTP hydrolysis should approximate kcat, and (ii) RGS
domain-mediated GAP activity should accelerate steady-state
GTP hydrolysis.
We tested these two predictions by performing steady-state
GTPase assays by using [-32P]GTP. The rate of GTP hydrolysis at
steady state (ks) at 20°C was 0.063 min1 (0.015 min1; n  4)
(Fig. 2F). Thus, the observed ks approximated the rate of nucleotide
hydrolysis, not nucleotide exchange, therefore satisfying the first
prediction. We observed that a 5-fold molar excess of AtRGS1 gave
a 35-fold increase in steady-state GTPase activity (Fig. 2F), satis-
fying the second prediction and validating that GTP hydrolysis is
the rate-limiting step in the Arabidopsis G protein cycle in vitro.
Under steady-state conditions, the fraction of G protein in the
active state can be approximated by kobs/(kobs  kcat) (SI Table 2)
(16). In the case of Go, for example, the percentage of protein
bound to GTP at steady state is predicted to be 10%. In stark
Fig. 1. Signal transduction by D-glucose is mediated by AtRGS1 and AtGPA1. (A) Seedlings of different genotypes were grown on 6% D-glucose, and the
percentage of seedlings with green cotyledons was quantified. All genotypes had 100% green seedlings when grown on 1% D-glucose. Genotypes: Col, wild-type
Columbia ecotype; Atrgs1–2, Atrgs1-null mutant; Atgpa1–4, Atgpa1-null mutant; 35S:AtRGS1(wild type: Ox9, Ox10, Ox16), three independent wild-type AtRGS1
constitutive overexpression lines; Atrgs1–2 Atgpa1–4, double-null mutant. Statistical significance was determined by Dunnett’s test (*, P  0.05 vs. Col). (B–G)
D-glucose-induced FRET between AtRGS1-YFP and AtGPA1-CFP in Arabidopsis roots was measured in vivo. Fluorescence emission for CFP excitation/YFP emission
(B and E) and CFP excitation/CFP emission (C and F) were captured 5 min (B and C) and 8 min (E and F) after the addition of D-glucose. The normalized net FRET
(nF/I) at 5 min (D) and 8 min (G) after D-glucose addition is shown. PM, plasma membrane. (H) Levels of nF/I were calculated every 30 s from 5 to 30 min after
addition of 6% (wt/vol) D-glucose, 6% (wt/vol) L-glucose, or no treatment controls. Red and blue lines show the observed FRET for the regions of interest (ROI)
1 and ROI 2, denoted in G. Black lines indicate other independent FRET efficiency measurements. Arrows indicate image capture time points of t  5 and t 
8 min, as denoted in B–G.
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contrast, the calculated value for AtGPA1 is 99% (SI Table 2).
Furthermore, AtGPA1 appears to have a higher affinity for GTP
than GDP (SI Table 1), further supporting the hypothesis that
AtGPA1 is constitutively present in the GTP-bound (and presumed
activated) form in vivo. This finding suggests that AtGPA1 may not
require GPCR-mediated GEF activity to accomplish signal trans-
duction as do all other known G subunits. In total, the biochemical
properties exhibited by AtGPA1 are consistent with this G subunit
being constitutively GTP-bound and thus a substrate for D-glucose-
regulated AtRGS1 GAP activity.
To test the hypothesis that GAP activity is the essential
regulatory function of AtRGS1 in D-glucose signaling, we engi-
neered a loss-of-function mutant in the RGS domain of AtRGS1
(Glu-320 to Lys) based on structural information of the RGS
domain–G interface (SI Fig. 6). Unlike the GAPs for Ras-
family GTPases, RGS proteins do not contribute a catalytic
residue per se to the chemistry of GTP hydrolysis that is intrinsic
to G, but instead bind most avidly to the G transition state
(i.e., between GTP and GDP/Pi-bound states) (17). Hence,
loss-of-function mutations to RGS domains such as E320K are
designed to eliminate GAP activity by disrupting the G-binding
interface (18). We analyzed the in vitro biochemical properties
of AtRGS1(E320K) by using a GST fusion of AtRGS1 (amino
acids 249–459). AtGPA1 GTPase activity was accelerated by
substoichiometric amounts of AtRGS1(wild type), whereas
AtRGS1(E320K) was ineffective over a wide range of concen-
trations. The E320K substitution reduced AtRGS1 GAP activity
by at least three orders of magnitude (Fig. 3A). Complementary
data were obtained by using single turnover and steady-state
time course assays (SI Figs. 7 and 8). To test that
AtRGS1(E320K) is deficient in its interaction with AtGPA1 as
well as in GAP activity, we measured the AtGPA1–AtRGS1
interaction by using surface plasmon resonance spectroscopy.
Consistent with published data (12), AtRGS1(wild-type) bound
AtGPA1 in the transition state for GTP hydrolysis (GDP-
AlF4), but not the ground (GDP; Fig. 3B) or activated (GTPS)
states (data not shown). Binding of AtGPA1 to AtRGS1(E320K)
could not be detected in any nucleotide state, thus verifying that
AtRGS1(E320K) is a true loss-of-function mutant. Equivalent
results were obtained by using GST coprecipitation assays (SI
Fig. 9).
We generated Arabidopsis lines expressing either untagged or
C-terminal GFP-fused AtRGS1(E320K). AtRGS1(E320K)-
GFP was observed to be plasma membrane-localized in the
hypocotyls, cotyledons, and roots in an identical pattern to
AtRGS1(wild-type)-GFP (Fig. 3 C–E) (5), indicating that
AtRGS1(E320K) is properly expressed, folded, and membrane-
targeted in vivo. Studies from mutants in the Arabidopsis G
protein pathway indicate a role for G protein signaling in
regulating cell growth. Dark-grown AtGPA1-deficient lines ex-
hibit reduced cell proliferation and consequently have a short-
ened hypocotyl (19), whereas AtRGS1-null seedlings have longer
hypocotyls because of increased cell elongation (5). In contrast,
seedlings overexpressing wild-type AtRGS1 have shortened
hypocotyls (5). Unlike AtRGS1(wild-type)-overexpressing
plants, AtRGS1(E320K)-expressing plants had wild-type-length
hypocotyls (Fig. 3F). Data obtained by using AtRGS1-GFP
fusion proteins expressed in AtRGS1-deficient plants confirm
that AtRGS1(E320K) cannot complement the Atrgs1-null mu-
tation (Fig. 3G). These results indicate that GAP activity is the
essential determinant in AtRGS1-mediated cell proliferative
signaling.
Fig. 2. Biochemical properties of AtGPA1. (A) Time course of [35S]GTPS binding to 100 nM AtGPA1 or GOA at 20°C. Data are the mean  SEM of duplicate
samples. Observed association rate constants (kobs) were: AtGPA1 1.44 [95% confidence interval (C.I.), 0.89–2.0] min1 and GOA 0.088 (95% C.I., 0.076–0.1)
min1. (B) Time course of BODIPYFL-GTPS binding to 200 nM AtGPA1 at 20°C. Data are plotted as the mean  SEM of three experiments. kobs  14.4 (95% C.I.,
12.5–16.2) min1. RFU, relative fluorescence units. (C) The tryptophan fluorescence of 100 nM AtGPA1 or buffer alone (control) was measured at 20°C. At 100 s,
GTPS was added to a final concentration of 1 M (arrow). Data are presented as the mean  SEM of duplicates. kobs  8.7 min1 (SEM  1.5 min1; n  3). (D)
Time course of [-32P]GDP dissociation from AtGPA1 at 20°C. Data are the mean  SEM of duplicates. Observed dissociation rate constant (koff) was 12.6 (95%
C.I., 4.4–21.0) min1. (E) Time course of single turnover [-32P]GTP hydrolysis by 200 nM AtGPA1 or GOA at 20°C. Data are the mean  SEM of duplicates. Rate
constants for GTP hydrolysis (kcat) were: AtGPA1 0.12 (95% C.I., 0.11–0.13) min1 and GOA 0.97 (95% C.I., 0.70–1.4) min1. (F) Time course of steady-state
[-32P]GTP hydrolysis by 200 nM AtGPA1 in the presence or absence of 1 M AtRGS1 at 20°C. Results are the mean  SEM of duplicate samples. Rates of Pi
production were AtGPA1 2.3 (95% C.I., 2.0–2.5)  102 cpm/min, AtGPA1AtRGS1 8.1 (95% C.I., 7.6–8.5)  103 cpm/min, and AtRGS1 alone 6.9 (95% C.I., 4.0–9.8) 
10 cpm/min.








We also measured the contribution of AtRGS1 GAP activity
to glucose-mediated growth arrest. Expression of the
AtRGS1(E320K) mutant was unable to complement Atrgs1-null
alleles and did not elicit the glucose-hypersensitive phenotype
typical of AtRGS1(wild-type)-overexpressing plants (compare
Fig. 1 A with Fig. 3H). This result suggests that the influence of
AtRGS1 on developmental responses to environmental glucose
is directly dependent on its GAP activity. This finding is con-
sistent with the hypothesis that AtRGS1 is a glucose-regulated
GAP for GTP-bound AtGPA1. Furthermore, the intrinsic bio-
chemical properties of high spontaneous nucleotide exchange
and low GTPase activity suggest that AtGPA1 is predominantly
in the GTP-bound state, and this state is the likely substrate for
AtRGS1 in vivo. The action of AtRGS1 is likely to be catalytic
because biochemical experiments demonstrate that AtRGS1 is a
potent accelerator of AtGPA1 GTPase activity at substoichio-
metric concentrations in vitro (Fig. 3A and SI Fig. 8). The in vitro
biochemical properties of AtGPA1 imply that the Arabidopsis G
protein cycle is distinct from the mammalian G protein cycle in
two critical aspects: GEF activity is not required, and GDP-
bound AtGPA1 may be the active signaling species in some cases.
These observations are concordant with data showing that
AtGPA1-GDP interacts with AtPLD1 to regulate phosphatidic
acid production and inhibition of stomatal opening (20).
Fig. 3. In vitro and in vivo characterization of AtRGS1(E320K) as a GAP-dead mutant. (A) Dose–response analysis of AtGPA1 steady-state GTPase acceleration
by wild type (WT) and E320K AtRGS1. GTPase assays were conducted for 20 min with 200 nM AtGPA1, and EC50 values were determined by regression for WT
as 2.7 (95% C.I., 2.4–3.1)  108 M and for the E320K mutant as 4.5 (95% C.I., 4.3–4.7)  105 M. For these EC50 regression analyses, it was assumed that the E320K
mutant has the same efficacy as WT protein. (B) Surface plasmon resonance was used to measure the interaction between AtRGS1 and AtGPA1. WT or E320K
GST-AtRGS1 was immobilized on a biosensor surface. Then 1 M AtGPA1 in the GDP or GDP-AlF4-bound form was injected over the biosensor surface.
Nonspecific binding to GST was subtracted from all curves. (C–E) AtRGS1(E320K)-GFP localization was visualized in Arabidopsis hypocotyls (C), cotelydons (D),
and roots (E) by using epifluorescence microscopy. (F) Hypocotoyl lengths of 2-day-old, dark-grown seedlings were measured. Genotypes: 35S:AtRGS1(WT or
E320K) (wild-type or E320K AtRGS1 constitutive overexpression lines). Multiple independent overexpression lines were generated and analyzed; individual lines
are denoted Ox. Statistical significance was determined by Bonferroni’s test (*, P  0.05 vs. Col). (G) Experiments were performed as in F, but Arabidopsis-
expressing AtRGS1-GFP-fusion proteins were used. Statistical significance was determined by Bonferroni’s test (*, P  0.05 vs. Col; #, P  0.05 vs. Atrgs1–2). (H)
Seedlings of the indicated genotypes were grown on 6% glucose, and the percentage of seedlings with green cotyledons was quantified. All genotypes had 100%
green seedlings when grown on 1% glucose. Genotypes are described in F. Statistical significance was determined by Bonferroni’s test (*, P  0.05 vs. Col; #, P 
0.05 vs. Atrgs1–2).
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In addition to AtRGS1, two other putative Arabidopsis
GPCRs, GCR1 and GCR2, have been described (21, 22). We
recently argued that GCR2 is not a transmembrane receptor, but
rather a plant homolog of bacterial lanthionine synthetases that
was misidentified as a GPCR (11). GCR1 is a predicted 7TM
protein reported to interact with AtGPA1 (23). Physiological
data suggest that GCR1 may be involved in the AtGPA1
signaling pathway (23). However, GCR1 also regulates hormonal
signaling in a G protein-independent manner (24). These reports
on GCR1 and GCR2 are entirely consistent with our findings
presented here, in that, to date, none of these plant proteins has
been shown to possess GEF activity toward the sole Arabidopsis
G subunit, AtGPA1. Thus, in light of the unique biochemical
activities of AtGPA1 as a rapid spontaneous exchanger and poor
GTPase, putative plant membrane receptors such as GCR1 also
may regulate AtGPA1 activity by GEF-independent
mechanisms.
Arabidopsis G subunits also are implicated in both cell
proliferation and sugar-sensing pathways (6, 19). The canonical
function for G subunits in metazoan organisms is to partici-
pate directly in GPCR-mediated GEF activity and regulate
effector pathways (1, 3). Although our data would appear to
exclude the former, it does not exclude the latter. G subunits
also are required for the proper membrane targeting and
stability of mammalian G subunits (25), and this finding
appears to be the case in Arabidopsis as well (26). Moreover,
FRET studies suggest that the Arabidopsis G heterotrimer
does not dissociate upon GTP binding, but merely changes
conformation (26). This result is in line with recent studies on
mammalian G protein signaling by nondissociated heterotrimers
(27), as well as those of the regulatory protein AGS8 shown to
facilitate signal transduction properties of a nondissociated
heterotrimer in complex with phospholipase C (28). Mamma-
lian G subunits also attenuate spontaneous nucleotide ex-
change on G subunits by 5-fold (29, 30). It is possible that
AtGPA1 constitutive activity is dampened by the Arabidopsis
G complex in vivo. However, to have a significant physiolog-
ical effect on AtGPA1 nucleotide cycling kinetics, Arabidopsis
G would need to attenuate GDP release by an improbable
three orders of magnitude (i.e., leading to a predicted GTP
occupancy of 10%), whereas a reduction in AtGPA1 GDP
release rate by two orders of magnitude is predicted to maintain
GTP occupancy level at 50% (data based on calculations
similar to those of SI Table 2).
We described genetic, biochemical, and cellular data on
AtRGS1 and AtGPA1 in support of a unique paradigm for
heterotrimeric G protein action. This AtRGS1-coupled, high-
glucose-sensing mechanism appears to be distinct from the most
thoroughly characterized plant glucose sensor, hexokinase (4).
This finding is not surprising because multiple sugar-sensing
mechanisms exist in plants (9, 31). Further studies should be
directed toward an unequivocal demonstration of glucose bind-
ing to AtRGS1 and glucose-mediated modulation of AtRGS1
GAP activity. This system is not unique to Arabidopsis because
we have identified AtRGS1 orthologs in several plant species (SI
Figs. 10–12). Moreover, we identified putative 7TM RGS pro-
teins in both fungi and protozoa as well (SI Figs. 10–12). These
findings suggest that many organisms may use 7TM RGS pro-
teins for glucose sensing and the control of cell proliferation.
Methods
Materials and Data Analysis. [35S]GTPS and [-32P]GTP were
from PerkinElmer (Wellesley, MA). [-32P]GDP was from MP
Biomedicals (Solon, OH). BODIPYFL-GTPS was from Mo-
lecular Probes (Eugene, OR). XTP and UTP were from Rob
Nicholas (University of North Carolina), and all other nucleo-
tides were obtained from Sigma–Aldrich (St. Louis, MO). Unless
otherwise specified, all other chemicals were of the highest
purity obtainable from Sigma–Aldrich or Fisher Scientific (Pitts-
burgh, PA). Nonlinear regression and statistical analyses were
performed in Prism version 4.0 (GraphPad, San Diego, CA). All
data presented are representative of three or more independent
experiments. Multiple comparison tests were calculated by
ANOVA by using either Dunnett’s or Bonferroni’s post-test at
the 95% significance level (Prism).
Protein Purification/Enzymology. His6-AtGPA1-GDP and GST-
AtRGS1 (amino acids 249–459) were purified as described (12).
Site-directed mutagenesis was conducted by using QuikChange
(Stratagene, La Jolla, CA). [35S]GTPS binding and [-32P]GTP
steady-state hydrolysis assays were conducted as described (32).
SPR assays using an anti-GST biosensor were conducted as
described (12, 18). GST, GST-AtRGS1(wild type), and GST-
AtRGS1(E320K) were immobilized to 240, 250, and 290 reso-
nance units (RU), respectively. Bulk buffer refractive index
change upon AtGPA1 injection was observed to increase re-
sponse units on all sensor surfaces equally by 200 RU. Bulk
shift and nonspecific binding were accounted for by subtraction
of simultaneous sensorgram curves derived from the GST-only
surface.
Intrinisic Tryptophan Fluorescence. Tryptophan fluorescence of G
was used as a probe for G protein activation (33). Structural and
mutagenic analyses indicate that a tryptophan residue in the
2-helix (switch-II), equivalent to W207 in Gt (34), shifts from
a solvent-exposed area to a hydrophobic pocket upon G
activation, resulting in an increased fluorescence quantum yield
(35). AtGPA1 also has this 2-helix tryptophan (W229). Tryp-
tophan fluorescence of AtGPA1 was measured at 20°C in 10 mM
TrisHCl (pH 8.0), 1 mM EDTA, and 10 mM MgCl2 by using a
PerkinElmer LS55 spectrophotometer. Excitation and emission
wavelengths were 282 and 340 nm, respectively, with slits widths
of 5 nm.
GDP Release. First, 100 nM AtGPA1 was preloaded with 3.2 nM
[-32P]GDP [3,000 Ci/mmol (1 Ci  37 GBq)] for 10 min at 20°C
in 20 mM TrisHCl (pH 8.0), 2 mM EDTA, 25 mM MgCl2, 100
mM NaCl, 1 mM DTT, and 0.1% (wt/vol) C12E10. Then, samples
were placed on ice, and aliquots were taken to assess total
[-32P]GDP bound. To quantify release of bound [-32P]GDP,
100 M GTPS was added, and reactions again were incubated
at 20°C. Aliquots were taken at indicated times, vacuum-filtered
onto HA45 nitrocellulose (Millipore, Billerica, MA), washed,
and analyzed by liquid scintillation. Data were plotted as amount
[-32P]GDP bound, with the initial preloaded aliquot serving as
zero time point, and fit to a single exponential decay function.
Single Turnover GTP Hydrolysis. The rate of GTP hydrolysis by
AtGPA1 was measured by a single turnover. Mg2 is a crucial
cofactor for GTP hydrolysis (16), and thus it is typically excluded
from the [-32P]GTP loading phase to prevent hydrolysis before
initiation of the single turnover reaction (36). However, AtGPA1
was observed to be highly dependent on Mg2 for GTP binding
(data not shown). Thus, we modified our standard method (32)
to account for [32Pi] release during preloading, as detailed in SI
Fig. 7.
Arabidopsis. All experiments were conducted by using Columbia
ecotype A. thaliana. Generation and characterization of the
majority of Arabidopsis lines containing T-DNA insertions and
transgenic alleles used in these studies are described (4, 5, 13).
Isolation of Atrgs1–2/Atgpa1–4 double mutants also has been
described (13). AtGPA1-L-CFP consists of enhanced cyan flu-
orescent protein inserted into the loop between the predicted A
and B helices (between Ala-97 and Gln-98) of AtGPA1 as
described (6, 13).








Plant Growth Assays. For phenotypic analyses, wild-type and
mutant seeds were sterilized; sown in Petri dishes containing 1/2
Murashige and Skoog basal medium with Gamborg’s vitamins
(ICN Biomedicals, Aurora, OH), 1% (wt/vol) sucrose, and 0.5%
(wt/vol) phytoagar (Research Products International, Mt. Pros-
pect, IL); adjusted to pH 5.7; and treated at 4°C in the dark for
3 days and then moved to a growth chamber with 23°C and light
intensity of 100 mol per m2/s. For the phenotypic analysis of
2-day-old etiolated seedlings, Petri dishes were wrapped in
aluminum foil and placed in the dark at 23°C. Etiolated hypo-
cotyls were measured by ruler.
AtRGS1 Transgenic Plants. The AtRGS1 ORF (At3g26090) was
PCR-amplified from cDNA made from seedlings grown in light
for 10 days, cloned into the pENTR/D-TOPO vector (Invitrogen,
Carlsbad, CA), and then subcloned into Gateway plant trans-
formation destination binary vector pB2GW7 or pGWB42 for
the AtRGS1-yellow fluorescent protein (YFP) fusion by attL/
attR site recombination reactions. The E320K mutation was
created by using QuikChange mutagenesis. In these constructs,
expression was driven by the 35S promoter of the caulif lower
mosaic virus. All constructs were transformed into Arabidopsis
plants of the indicated genotypes by Agrobacterium-mediated
transformation (37), and expression of all transgenes was verified
by RT-PCR (SI Fig. 13).
Green Seedling Assay. The green seedling assay was performed
largely according to published protocols (4). Briefly, wild-type
(Col-0), mutant, and transgenic seeds were sown, chilled, light
treated, and grown under identical conditions until maturation.
Seeds from matched lots were sterilized with 80% (vol/vol)
ethanol for 2 min, followed by 30% (vol/vol) bleach with 0.1%
(vol/vol) Tween-20 for 10 min, and then washed with sterile
deionized water six times under sterile conditions. Sterilized
seeds were sown on plates consisting of 1/2 Murashige and Skoog
basal medium with vitamins (Plantmedia, Dublin, OH) (pH
adjusted to 5.7 with 1 N KOH), 0.5% (wt/vol) phytoagar
(Plantmedia) and different concentrations of D-glucose (Sigma–
Aldrich) and stratified at 4°C in the dark for 48 h. Then plates
were moved to a 23°C growth chamber, under 16/8-h photo-
period at 100 mol/m2/s, and placed horizontally. Ten days later,
the percentage of green seedling was scored as the number of
green seedlings divided by the total number of seeds. Each
experiment was repeated three times. Minimally, 50 seeds were
scored for each treatment of each genotype.
FRET Microscopy. Fluorescence images of AtRGS1-YFP/AtGPA1-
L-CFP seedlings were captured by using an Olympus IX81 inverted
microscope (Center Valley, PA) controlled by IPlab software
version 3.6 (BD Biosciences, Rockville, MA). Images of CFP, YFP,
and the YFP/CFP ratio were observed through a 60 water
immersion objective and simultaneously captured by a cooled
charge-coupled device Photometrics Cascade Digital Camera
(Roper Scientific, Tucson, AZ) equipped with CFP/YFP FRET
emission filter OI-05-EM in a dual-view mounting tube. Filter sets
used were YFP (excitation, 500/20 nm; emission, 535/30 nm), CFP
(excitation, 436/20 nm; emission, 480/40 nm), and FRET (505dcxr;
excitation, 436/20 nm; emission, 480/30 nm and 535/40 nm). Nor-
malized net FRET was calculated in IPlab version 3.6 software
using established algorithms for two-filter FRET with fluorescence
microscopy (38).
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